Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

Myasthenia Gravis

(2016) Nils E. Gilhus   NEW ENGLAND JOURNAL OF MEDICINE

Myasthenia gravis: subgroup classification and therapeutic strategies

(2015) Nils Erik Gilhus et al.   LANCET NEUROLOGY

The emerging role of tacrolimus in myasthenia gravis

(2015) Jennifer L. Cruz et al.   Therapeutic Advances in Neurological Disorders

Recommendations for myasthenia gravis clinical trials

(2012) Michael Benatar et al.   MUSCLE & NERVE

Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis

(2011) C.-B. Zhao et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis

(2011) H. Yoshikawa et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Guidelines for treatment of autoimmune neuromuscular transmission disorders

(2010) G. O. Skeie et al.   EUROPEAN JOURNAL OF NEUROLOGY

Nationwide Population-Based Epidemiological Study of Myasthenia Gravis in Taiwan

(2010) Chien-Hsu Lai et al.   NEUROEPIDEMIOLOGY

Tacrolimus for Myasthenia Gravis

(2008) José M. Ponseti et al.   Annals of the New York Academy of Sciences

Long-term Treatment of Steroid-dependent Myasthenia Gravis Patients with Low-dose Tacrolimus

(2008) Akiko Nagaishi et al.   INTERNAL MEDICINE

Terbutaline in myasthenia gravis: A pilot study

(2008) Betty Soliven et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Current and future standards in treatment of myasthenia gravis

(2008) Ralf Gold et al.   Neurotherapeutics